GlassScriptPhysician profile
John Zvijac
NPI 1316913163
$175,957.92
in general payments reported to CMS, 2019-2025
14 companies · $25K in 2025
The $25K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $72K · 2021: $16K · 2022: $4,549 · 2023: $9,338 · 2024: $21K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Food and Beverage: $1,998 · Travel and Lodging: $1,290 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,025.00 |
| Food and Beverage | $1,998.42 |
| Travel and Lodging | $1,290.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $79,304.38 | 2020-2024 | Ovomotion, Ovo Motion, Revomotion |
| Arthrex, INC. | $50,320.81 | 2019-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $35,553.84 | 2019-2020 | |
| Depuy Synthes Products, INC. | $3,932.50 | 2019-2022 | |
| Arthrosurface Incorporated | $3,882.88 | 2019-2025 | Ovomotion |
| Southern Edge Orthopaedics, INC. | $1,423.44 | 2022-2025 | |
| Smith+Nephew, INC. | $659.16 | 2019-2025 | Ultrabutton, Spatial Frame, Pico 14 |
| Depuy Synthes Sales INC. | $375.37 | 2020-2025 | Truespan Orthocord, Vapr |
| Vericel Corporation | $158.20 | 2021-2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $121.87 | 2019 | |
| Miach Orthopaedics, INC. | $112.78 | 2023 | |
| Curonix LLC | $49.55 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Organogenesis INC. | $31.60 | 2020 | |
| Axogen | $31.54 | 2023 | Avance Nerve Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,401.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zvijac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.